{
  "trial_id": "NCT00420095",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, type of diabetes (Type 1 or Type 2), duration of diabetes, baseline HbA1c, body mass index (BMI), daily insulin dose, history of severe hypoglycemia, compliance with diet and insulin therapy, frequency of blood glucose monitoring.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Type of Diabetes",
          "type of diabetes (Type 1 or Type 2)"
        ],
        [
          "Baseline Glycosylated Hemoglobin",
          "baseline HbA1c"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Duration of Diabetes",
          "duration of diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Other Treatments for Diabetes Prior to Study",
        "Race/Ethnicity",
        "Baseline Fasting Blood Glucose",
        "Duration of Insulin Treatment"
      ],
      "remaining_candidate_features": [
        "Age",
        "daily insulin dose",
        "history of severe hypoglycemia",
        "compliance with diet and insulin therapy",
        "frequency of blood glucose monitoring."
      ]
    },
    "processed-gen-response": "Age, gender, type of diabetes (Type 1 or Type 2), duration of diabetes, baseline HbA1c, body mass index (BMI), daily insulin dose, history of severe hypoglycemia, compliance with diet and insulin therapy, frequency of blood glucose monitoring."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Type of Diabetes (Type 1 or Type 2), Duration of Diabetes, Baseline HbA1c, Body Mass Index, Total Daily Insulin Dose, Frequency of Severe Hypoglycemia, Compliance with Diet and Insulin Therapy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Type of Diabetes",
          "Type of Diabetes (Type 1 or Type 2)"
        ],
        [
          "Baseline Glycosylated Hemoglobin",
          "Baseline HbA1c"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ],
        [
          "Duration of Diabetes",
          "Duration of Diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Other Treatments for Diabetes Prior to Study",
        "Baseline Fasting Blood Glucose",
        "Duration of Insulin Treatment"
      ],
      "remaining_candidate_features": [
        "Age",
        "Total Daily Insulin Dose",
        "Frequency of Severe Hypoglycemia",
        "Compliance with Diet and Insulin Therapy"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Type of Diabetes (Type 1 or Type 2), Duration of Diabetes, Baseline HbA1c, Body Mass Index, Total Daily Insulin Dose, Frequency of Severe Hypoglycemia, Compliance with Diet and Insulin Therapy"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "##Answer:\nAge, Continuous, Sex: Female, Male, Diabetes Type, Duration of Diabetes, Body Mass Index, HbA1c, Insulin Dose, Region of Enrollment,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Type of Diabetes",
          "Diabetes Type"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ],
        [
          "Duration of Diabetes",
          "Duration of Diabetes"
        ],
        [
          "Baseline Glycosylated Hemoglobin",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Other Treatments for Diabetes Prior to Study",
        "Race/Ethnicity",
        "Baseline Fasting Blood Glucose",
        "Duration of Insulin Treatment"
      ],
      "remaining_candidate_features": [
        "Age",
        "Insulin Dose"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Diabetes Type, Duration of Diabetes, Body Mass Index, HbA1c, Insulin Dose, Region of Enrollment"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, body mass index (BMI), duration of diabetes, type of diabetes (type 1 or type 2), HbA1c at baseline, fasting plasma glucose at baseline, insulin dose at baseline, history of severe hypoglycemia, presence of diabetic complications (e.g. retinopathy, nephropathy, neuropathy).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Duration of Diabetes",
          "duration of diabetes"
        ],
        [
          "Type of Diabetes",
          "type of diabetes (type 1 or type 2)"
        ],
        [
          "Baseline Glycosylated Hemoglobin",
          "HbA1c at baseline"
        ],
        [
          "Baseline Fasting Blood Glucose",
          "fasting plasma glucose at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Other Treatments for Diabetes Prior to Study",
        "Race/Ethnicity",
        "Duration of Insulin Treatment"
      ],
      "remaining_candidate_features": [
        "Age",
        "insulin dose at baseline",
        "history of severe hypoglycemia",
        "presence of diabetic complications (e.g. retinopathy, nephropathy, neuropathy)"
      ]
    },
    "processed-gen-response": "Age, sex, body mass index (BMI), duration of diabetes, type of diabetes (type 1 or type 2), HbA1c at baseline, fasting plasma glucose at baseline, insulin dose at baseline, history of severe hypoglycemia, presence of diabetic complications (e.g. retinopathy, nephropathy, neuropathy)."
  }
}